|
BI-D1870 (CAS: 501437-28-1)
|
| SKU-Pack Size | Availability | Size | Price | |
| EBC51067-1ML | In Stock | 1mL(10mM in DMSO) | €180.70 | |
| EBC51067-2MG | In Stock | 2mg | €115.70 | |
| EBC51067-5MG | In Stock | 5mg | €154.70 | |
| EBC51067-10MG | In Stock | 10mg | €232.70 | |
| EBC51067-50MG | In Stock | 50mg | €648.70 |
| Please Select The Country You Are In To Find Your Local Distributor. |
| Dianost | Phone£º+49 (0) 40 65472-053 | |
| Bullenkoppel 11£¬ 23896 Poggensee, | E-mail£ºola@olasciences.com | |
| Germany | Germany | Web£ºwww.olasciences.com |
| Product Information | |||||||||||||||||||||
| Synonym(s) | RSK inhibitor | ||||||||||||||||||||
| Chemical Name | 2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone | ||||||||||||||||||||
| Application | BI-D1870 is a cell permeable, ATP-competitive inhibitor of the four isoforms of ribosomal S6 kinase (p90 RSK) | ||||||||||||||||||||
| CAS Number | 501437-28-1 | ||||||||||||||||||||
| Purity | ¡Ý99.0% | ||||||||||||||||||||
| Molecular Weight | 391.40 | ||||||||||||||||||||
| Molecular Formula | C₁₉H₂₃F₂N₅O₂ | ||||||||||||||||||||
| SMILES | CC1C(=O)N(C2=CN=C(N=C2N1CCC(C)C)NC3=CC(=C(C(=C3)F)O)F)C | ||||||||||||||||||||
| Target & IC50 | Rsk-1 : IC50 = 31 nM Rsk-2: IC50 = 24 nM Rsk-3: IC50 = 18 nM Rsk-4: IC50 = 15 nM |
||||||||||||||||||||
| Solubility | DMSO: 72 mg/mL (183.9 mM) | ||||||||||||||||||||
| Preparing Stock Solutions |
|
||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||
| Storage | Store at -20¡ãC | ||||||||||||||||||||
| Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. | ||||||||||||||||||||
| Product Description | |
BI-D1870 is a cell permeable, ATP-competitive inhibitor of the four isoforms of ribosomal S6 kinase (p90 RSK) (IC50′s at 100μM ATP: Rsk-1 = 31nM, Rsk-2 = 24nM, Rsk-3 = 18nM, Rsk-4 = 15nM). BI-D1870 does not significantly inhibit 10 other AGC kinases, and over 40 other protein kinases at 100X concentrations. BI-D1870 acts on the N-terminal AGC kinase domain and completely prevents PMA-induced TSC2 phosphorylation. |
| Specific Protocols | |